SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-070732
Filing Date
2023-03-15
Accepted
2023-03-15 08:19:32
Documents
16
Period of Report
2023-03-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d398207d8k.htm   iXBRL 8-K 26468
2 EX-99.1 d398207dex991.htm EX-99.1 14286
6 GRAPHIC g398207dsp5.jpg GRAPHIC 14652
7 GRAPHIC g398207dsp5a.jpg GRAPHIC 6446
8 GRAPHIC g398207dsp5b.jpg GRAPHIC 2282
  Complete submission text file 0001193125-23-070732.txt   198013

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rprx-20230315.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rprx-20230315_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rprx-20230315_pre.xml EX-101.PRE 10816
10 EXTRACTED XBRL INSTANCE DOCUMENT d398207d8k_htm.xml XML 3455
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39329 | Film No.: 23733366
SIC: 2834 Pharmaceutical Preparations